Article Details

Gemini Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Retrieved on: 2021-04-13 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Gemini Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4). View article details on hiswai:

Excerpt

... and monoclonal antibodies and is advancing a potentiating antibody for CFH, GEM307, into clinical development for treatment of systemic diseases.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo